- Home
- PRAX vs CASH Comparison
PRAX vs CASH Comparison
Compare PRAX & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- CASH
- Stock Information
- Founded
- PRAX 2015
- CASH 1954
- Country
- PRAX United States
- CASH United States
- Employees
- PRAX N/A
- CASH N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- CASH Major Banks
- Sector
- PRAX Health Care
- CASH Finance
- Exchange
- PRAX Nasdaq
- CASH Nasdaq
- Market Cap
- PRAX 1.5B
- CASH 1.8B
- IPO Year
- PRAX 2020
- CASH N/A
- Fundamental
- Price
- PRAX $70.54
- CASH $77.74
- Analyst Decision
- PRAX Strong Buy
- CASH Hold
- Analyst Count
- PRAX 9
- CASH 3
- Target Price
- PRAX $146.33
- CASH $80.67
- AVG Volume (30 Days)
- PRAX 309.5K
- CASH 206.9K
- Earning Date
- PRAX 03-04-2025
- CASH 01-21-2025
- Dividend Yield
- PRAX N/A
- CASH 0.26%
- EPS Growth
- PRAX N/A
- CASH 10.58
- EPS
- PRAX N/A
- CASH 6.62
- Revenue
- PRAX $1,605,000.00
- CASH $711,045,000.00
- Revenue This Year
- PRAX N/A
- CASH N/A
- Revenue Next Year
- PRAX N/A
- CASH $5.10
- P/E Ratio
- PRAX N/A
- CASH $11.74
- Revenue Growth
- PRAX N/A
- CASH 10.44
- 52 Week Low
- PRAX $33.01
- CASH $46.68
- 52 Week High
- PRAX $86.93
- CASH $86.00
- Technical
- Relative Strength Index (RSI)
- PRAX 46.51
- CASH 55.51
- Support Level
- PRAX $60.07
- CASH $76.39
- Resistance Level
- PRAX $71.21
- CASH $77.84
- Average True Range (ATR)
- PRAX 4.07
- CASH 1.85
- MACD
- PRAX -0.79
- CASH 0.56
- Stochastic Oscillator
- PRAX 49.11
- CASH 93.28
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About CASH Pathward Financial Inc.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.